McCall AL, Farhy LS. Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. Minerva Endocrinol. 2013;38(2):145-63.McCall AL, Farhy LS: Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control. Minerva Endocrinol 2013, 38...
Non-insulin pharmacological therapies for treating type 1 diabetes. Expert Opin Pharmacother. (2018) 19:947-60. doi: 10.1080/14656566.2018. 1483339Christian Seerup, Frandsen,Thomas Fremming,etc.Non-insulin pharmacological therapies for treating type 1 diabetes.[J].2018,19(9)....
Skipping insulin Weight fluctuations What is diabulimia? The word “diabulimia” is a media-coined term used to describe a combination of “diabetes” and “bulimia.” However, people with type 1 diabetes can develop any type of eating disorder, not just bulimia. A dual diagnosis of an eating...
International Journal of Current Medical and Pharmaceutical Research INSULIN REGIMEN FOR THE TREATMENT OF DIABETES MELITUS Diabetes mellitus type 1 is a form of diabetes in which not enough insulin is produced. The lack of insulin results in high blood sugar levels. The classical symptoms are frequen...
Type 2 diabetes (T2D) typically starts with insulin resistance in peripheral tissues and proceeds with gradual loss of islet function due to the reduction in β-cell mass or dedifferentiation of β cells1,2. More than 30% of T2D patients eventually rely on exogenous insulin treatment. Cadaveric...
Type 1 diabetes is an autoimmune disease that causes loss of pancreatic beta cells, which produce endogenous insulin. To replace that, patients must take exogenous insulin by shots or pump and are at risk of dangerous low blood sugar events. There is no current oral treatment for this d...
While diabetes gets a lot of attention, people with Type 1 diabetes (T1D) are frequently overlooked when drug companies develop new medications. Consider this information to better understand the challenges and risks of complications these patients face.
Insulin analogues in type 1 diabetes mellitus: getting better all the time. Nat. Rev. Endocrinol. 13, 385–399 (2017). Article CAS PubMed Google Scholar Wu, K. K. & Huan, Y. Streptozotocin‐induced diabetic models in mice and rats. Curr. Protoc. Pharmacol. 40, 5.47.1–5.47.14 (...
Type 1 diabetes (T1D), often called insulin-dependent or immune-mediated diabetes, is usually diagnosed in children or young adults but can develop at any age. About 5% to 10% of those affected by diabetes have T1D, which develops because of the cellular-mediated autoimmune destruction of th...
Type 1 diabetes (T1D; also known as type 1 diabetes mellitus and immune-mediated diabetes) is a multifactorial autoimmune disease in which insulin-producing beta cells in pancreatic islets are destroyed by autoreactive T cells. Mononuclear cells infiltrate the pancreatic islets of Langerhans during ...